GlassScriptPhysician profile
Phillip Savage
NPI 1386094142
$1,354.32
in general payments reported to CMS, 2019-2025
15 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $199 · 2020: $47.01 · 2021: $254 · 2022: $255 · 2023: $116 · 2024: $131 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $598.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $599.87 | 2021-2025 | Stravix, Regranex, Collagenase Santyl |
| Depuy Synthes Sales INC. | $191.74 | 2025 | Motoband, Minibunion, Na |
| Zimmer Biomet Holdings, INC. | $99.35 | 2019-2023 | Subchondroplasty Knee Kit |
| Wright Medical Technology, INC. | $88.70 | 2019-2020 | |
| Paragon 28, INC. | $62.84 | 2019-2023 | Portfolio |
| Anika Therapeutics, INC. | $50.54 | 2021 | |
| Treace Medical Concepts, INC. | $46.31 | 2025 | |
| Medartis INC. | $44.34 | 2025 | Aptus |
| Bioventus LLC | $38.30 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Arteriocyte Medical Systems, INC. | $34.54 | 2019 | |
| Stryker Corporation | $34.19 | 2023 | Prophecy, Ortholoc 3di |
| Fusion Orthopedics USA, LLC | $22.13 | 2024 | |
| Axogen | $17.74 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Ossur Americas, INC. | $15.61 | 2025 | |
| Kerecis Limited | $8.12 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phillip Savage listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.